Carl Zeiss Meditec's INTRABEAM Targeted Intraoperative Radiotherapy System Demonstrates that Single-dose Radiation is Equivalent to Prolonged Courses of Post-operative Radiation for Early Breast Cancer Treatment CHICAGO, IL--(Marketwire - June 7, 2010) -  Carl Zeiss Meditec announced that outcomes for the TARGIT-A multicenter clinical trial, which used the INTRABEAM® System to deliver a single dose...

Targeted Intraoperative Radiotherapy (TARGIT) Clinical Trial Outcomes Demonstrate the Potential for Single-Dose Radiation Therapy to Become the New Standard of Care in Breast Cancer Therapy CHICAGO, IL--(Marketwire - June 5, 2010) -  TARGIT-A, the largest randomized clinical trial conducted in the field of intra-operative radiotherapy (IORT) for the treatment of breast cancer, has...

TARGIT Intraoperative Radiation Therapy: Long Awaited Results of the TARGeted Intraoperative radioTherapy (TARGIT) Trial to Be Announced at ASCO 2010 LONDON--(Marketwire - May 26, 2010) -  Patients with breast cancer await with interest the outcomes of a study exploring the role of targeted intra-operative radiotherapy using the...

Clinical Data for Carl Zeiss Meditec's INTRABEAM Targeted Intraoperative Radiotherapy System for Breast Cancer to Be Presented at ASCO 2010 JENA, GERMANY and DUBLIN, CA--(Marketwire - May 26, 2010) -  Carl Zeiss Meditec announced that the TARGIT-A (TARGeted Intra-operative radiation Therapy) multicenter clinical trial that used the...